Cyclo Therapeutics, Inc.
Index- P/E- EPS (ttm)-1.87 Insider Own5.40% Shs Outstand8.41M Perf Week-3.81%
Market Cap16.60M Forward P/E- EPS next Y-1.75 Insider Trans10.54% Shs Float7.63M Perf Month-6.48%
Income-13.00M PEG- EPS next Q-0.54 Inst Own5.20% Short Float0.12% Perf Quarter-36.28%
Sales1.40M P/S11.86 EPS this Y59.90% Inst Trans-5.11% Short Ratio0.35 Perf Half Y-49.50%
Book/sh1.55 P/B1.30 EPS next Y23.60% ROA-85.70% Target Price10.00 Perf Year-79.88%
Cash/sh1.44 P/C1.41 EPS next 5Y- ROE-109.70% 52W Range1.88 - 10.40 Perf YTD-45.84%
Dividend- P/FCF- EPS past 5Y19.60% ROI-90.40% 52W High-80.58% Beta-0.63
Dividend %- Quick Ratio5.40 Sales past 5Y1.10% Gross Margin89.40% 52W Low7.45% ATR0.19
Employees9 Current Ratio5.50 Sales Q/Q-50.00% Oper. Margin- RSI (14)42.42 Volatility9.59% 9.17%
OptionableNo Debt/Eq0.00 EPS Q/Q56.50% Profit Margin- Rel Volume0.31 Prev Close1.97
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume26.13K Price2.02
Recom2.00 SMA20-7.35% SMA50-12.08% SMA200-50.09% Volume8,108 Change2.54%
Jun-21-22 08:05AM  
May-18-22 08:00AM  
May-12-22 04:05PM  
May-09-22 08:05AM  
Mar-29-22 08:35AM  
Mar-24-22 08:05AM  
Mar-23-22 08:25AM  
Mar-14-22 08:05AM  
Mar-10-22 08:05AM  
Feb-08-22 08:05AM  
Feb-03-22 08:05AM  
Jan-20-22 08:05AM  
Jan-12-22 10:35AM  
Dec-16-21 06:16AM  
Dec-09-21 08:05AM  
Dec-06-21 08:05AM  
Nov-16-21 08:28PM  
Nov-15-21 04:20PM  
Nov-10-21 08:05AM  
Nov-04-21 02:30PM  
Nov-02-21 08:05AM  
Oct-19-21 09:15AM  
Oct-18-21 08:05AM  
Oct-06-21 08:05AM  
Sep-27-21 08:05AM  
Sep-15-21 08:05AM  
Sep-08-21 08:05AM  
Aug-17-21 08:05AM  
Jul-30-21 08:05AM  
Jul-27-21 08:05AM  
Jun-21-21 08:05AM  
Jun-19-21 03:37AM  
Jun-17-21 08:05AM  
Jun-15-21 08:05AM  
Jun-14-21 08:05AM  
Jun-12-21 04:06AM  
Jun-09-21 08:05AM  
May-20-21 09:05AM  
May-17-21 09:05AM  
May-11-21 09:05AM  
Apr-27-21 09:05AM  
Apr-20-21 09:25AM  
Mar-25-21 08:35AM  
Mar-15-21 08:05AM  
Mar-12-21 08:05AM  
Mar-10-21 08:35AM  
Mar-09-21 09:05AM  
Mar-04-21 09:10AM  
Mar-01-21 09:05AM  
Feb-22-21 09:00AM  
Feb-09-21 08:05AM  
Jan-26-21 08:00AM  
Jan-05-21 08:00AM  
Dec-22-20 02:30PM  
Dec-12-20 02:01AM  
Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ostronic Francis PatrickDirectorMay 20Buy2.045,00010,199138,525May 23 10:00 AM
TATE JEFFREYChief Operating OfficerMay 16Buy2.123,0006,35432,160May 16 01:01 PM
TATE JEFFREYChief Operating OfficerApr 29Buy2.701,3653,69229,160Apr 29 03:36 PM
TATE JEFFREYChief Operating OfficerApr 28Buy2.506351,58827,795Apr 29 03:36 PM
Sieger MarkusDirectorMar 29Buy2.7310,00027,30081,689Mar 30 10:28 AM
FINE N SCOTTChief Executive OfficerFeb 07Buy3.5810,33436,996145,000Feb 07 03:50 PM
Ostronic Francis PatrickDirectorJan 24Buy3.752,0007,500113,211Jan 24 11:14 AM
FINE N SCOTTChief Executive OfficerJan 19Buy3.895,00019,450134,666Jan 19 02:59 PM
Ostronic Francis PatrickDirectorJan 19Buy4.001,1324,528111,211Jan 19 02:38 PM
Ostronic Francis PatrickDirectorJan 14Buy4.001,7316,924110,079Jan 18 09:00 AM
Ostronic Francis PatrickDirectorJan 14Buy4.002,1378,548108,348Jan 14 02:47 PM
FINE N SCOTTChief Executive OfficerDec 15Buy3.895,00019,450129,666Dec 15 11:19 AM
Ostronic Francis PatrickDirectorDec 15Buy3.903,00011,700106,211Dec 15 11:20 AM
Ostronic Francis PatrickDirectorDec 10Buy4.405,00022,000103,211Dec 10 02:23 PM
Ostronic Francis PatrickDirectorDec 03Buy4.758644,10498,211Dec 06 07:32 AM
Hrynkow Sharon HemondChief Scientific OfficerDec 02Buy4.981,0004,98019,350Dec 02 04:54 PM
FINE N SCOTTChief Executive OfficerDec 02Buy4.935,00024,650124,666Dec 02 04:34 PM
Ostronic Francis PatrickDirectorDec 02Buy4.754,13619,64697,347Dec 02 03:46 PM
Ostronic Francis PatrickDirectorDec 01Buy5.005,00025,00093,211Dec 01 05:48 PM
FINE N SCOTTChief Executive OfficerNov 19Buy5.255,00026,250119,666Nov 19 01:05 PM
Ostronic Francis PatrickDirectorNov 19Buy5.2510,65255,90388,211Nov 19 12:50 PM
Ostronic Francis PatrickDirectorOct 29Buy5.901,0005,90077,559Nov 01 07:30 AM
FINE N SCOTTChief Executive OfficerSep 15Buy6.355,00031,750114,666Sep 15 03:39 PM